Table 3.
Characteristic | HbA1C < 7% | Achieving ≥ 2 treatment goals** | ||
---|---|---|---|---|
PR (95% CI) | P | PR (95% CI) | P | |
Sex (reference: men) | ||||
Women | 1.13 (1.07–1.20) | < 0.001 | 1.05 (1.00–1.11) | 0.050 |
Age (years, reference: ≤ 54) | ||||
> 54 to ≤ 64 | 1.03 (0.95–1.11) | 0.453 | 1.01 (0.94–1.08) | 0.836 |
> 64 to ≤ 74 | 1.08 (0.99–1.17) | 0.080 | 1.03 (0.96–1.11) | 0.415 |
≥ 74 | 1.20 (1.08–1.34) | < 0.001 | 1.02 (0.91–1.04) | 0.646 |
Race (reference: white) | ||||
Black | 0.91 (0.83–1.00) | 0.041 | 0.86 (0.79–0.94) | < 0.001 |
Pardo (mixed) | 1.01 (0.95–1.08) | 0.701 | 0.95 (0.90–1.02) | 0.139 |
Yellow/indigenous | 1.05 (0.93–1.19) | 0.433 | 0.94 (0.83–1.06) | 0.307 |
Education (reference: university) | ||||
Less than university | 0.94 (0.86–1.01) | 0.101 | 0.97 (0.91–1.04) | 0.419 |
Private health insurance (reference: no) | ||||
Yes | 1.07 (0.99–1.15) | 0.083 | 1.15 (1.07–1.23) | < 0.001 |
Per capita income (minimum wages/mo. Reference: less than 4)1 | ||||
4 to < 8 | 1.20 (1.07–1.34) | 0.002 | 1.12 (1.01–1.23) | 0.031 |
8 to < 12 | 1.16 (1.02–1.32) | 0.023 | 1.11 (1.00–1.25) | 0.061 |
12 to < 16 | 1.27 (1.11–1.45) | 0.001 | 1.18 (1.05–1.33) | 0.007 |
≥ 16 | 1.26 (1.10–1.45) | 0.001 | 1.19 (1.06–1.34) | 0.004 |
Body mass index (increase of 5 kg/m2) | 0.97 (0.95–1.00) | 0.087 | 0.96 (0.94–0.99) | 0.012 |
Diabetes medication | ||||
Yes | 1.03 (0.94–1.12) | 0.535 | 1.03 (0.95–1.12) | 0.507 |
Years since diabetes diagnosis (reference: 0–1) | ||||
1–10 | 0.74 (0.71–0.77) | < 0.001 | 0.87 (0.82–0.91) | 0.001 |
10 + | 0.43 (0.39–0.47) | < 0.001 | 0.68 (0.63–0.73) | < 0.001 |
*through Poisson regression with robust variance for age, sex, educational achievement, race/skin color, private health insurance, per capita income, diabetes medication, body mass index, and years since diagnosis
**Treatment goals: glucose, blood pressure and LDL-c
1Minimum wage: the monthly minimum wage was BRL 986.00 at the time of the study